PATH vs PDEX
Uipath Inc (PATH) versus Pro-Dex Inc (PDEX) — a side-by-side from cached financials, not a winner call.
Uipath Inc (PATH) is a software - infrastructure company listed on US.
Pro-Dex Inc (PDEX) is a medical instruments & supplies company listed on US.
Latest reported PATH revenue for 2026-01-31 was $1.61B. Net income was $282.3M. Revenue was up 12.7% from 2025-01-31 to 2026-01-31. PATH currently screens at market cap $6.07B and trailing P/E 19.4.
Latest reported PDEX revenue for 2025-06-30 was $66.6M. Net income was $155.0K. Revenue was up 23.7% from 2024-06-30 to 2025-06-30. PDEX currently screens at market cap $146.4M and trailing P/E 16.3.
PATH currently screens at market cap $6.07B and trailing P/E 19.4. PDEX currently screens at market cap $146.4M and trailing P/E 16.3.
Not investment advice. Open the PATH and PDEX stock pages for the full models.
Not investment advice.